Featured News

Meet our runners for the 2022 TCS NYC Marathon!

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.

Joining or creating a team for the Virtual Turkey Trot can boost your fundraising goals and accelerate the diagnosis and treatment of celiac disease.  

Listen in as Marilyn G. Geller, Chief Executive Officer of the Celiac Disease Foundation, talks with Mike and Cam at the Celiac Project Podcast about some of the exciting work we’re doing.

The Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, announced today that Amanda Halligan has been named Director of Marketing and Communications.

Join Columbia University for an educational event on August 19th on the management of celiac disease after diagnosis. This is the second in a series of 10 bimonthly programs and is open to healthcare professionals and patients.

iCureCeliac® is the Foundation’s patient-powered tool that is the single best resource for celiac disease researchers around the world helping to accelerate the search for treatments and a cure.

We are pleased to introduce a new 7-Day Mediterranean Diet Meal Plan, developed by Janelle Smith, Registered Dietitian at UCLA.

The risk of developing CAD in celiac patients was found to be higher for white males, and patients with celiac disease and CAD are more likely to have disorders such as high cholesterol, type 2 diabetes, and iron-deficiency anemia.  

Last week in Washington, D.C., the Celiac Disease Foundation and our allies secured two critical wins in our mission to drive policy change to improve the health of those living with celiac disease.